Finance

Lists
6Y4:FRA
Vicore Pharma Holding AB
€0.95
-0.21%
(-0.0020) 1D
Sep 3, 8:01:03 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6Y4...
Open
€0.95
High
€0.95
Low
€0.95
Mkt. cap
3.10B
Avg. vol.
0.00
Volume
0.00
52-wk high
€1.86
52-wk low
€0.81
No. of employees
46
Open
€0.95
High
€0.95
Low
€0.95
Mkt. cap
3.10B
Avg. vol.
0.00
Volume
0.00
52-wk high
€1.86
52-wk low
€0.81
No. of employees
46
News stories
From web sources and news partners
About Vicore Pharma Holding AB
CEO-
Employees46
Founded2000
Headquarters-
SectorBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
760.00K
419.00K
602.00K
2.21M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
99.16M
113.04M
102.60M
118.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.65M
22.06M
21.51M
33.02M
Operating expense
116.81M
135.10M
124.11M
151.87M
Total operating expenses
116.81M
135.10M
124.11M
151.87M
Operating income
-116.05M
-134.68M
-123.50M
-149.65M
Other non operating income
1.00K
-
-
-
EBT including unusual items
-113.47M
-137.10M
-108.53M
-142.67M
EBT excluding unusual items
-113.47M
-137.10M
-108.53M
-142.67M
Income tax expense
-
-
86.00K
173.00K
Effective tax rate
-
-
-0.08%
-0.12%
Other operating expenses
-
-
-
-
Net income
-113.47M
-137.10M
-108.62M
-142.84M
Net profit margin
-14,930.66%
-32,721.48%
-18,042.52%
-6,454.77%
Earnings per share
-0.48
-0.54
-0.39
-0.51
Interest and investment income
5.96M
45.52M
15.96M
7.43M
Interest expense
-3.47M
-
-643.00K
-1.00K
Net interest expenses
2.49M
45.52M
15.32M
7.43M
Depreciation and amortization charges
-
-
-
-
EBITDA
-115.49M
-134.12M
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps